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Cervical cancer is a life-threatening complication, appearing as the uncontrolled growth of abnormal cells in the lining of the cervix.
Every year, increasing numbers of cervical cancer cases are reported worldwide. Different identification strategies were proposed
to detect cervical cancer at the earlier stages using various biomarkers. Squamous cell carcinoma antigen (SCC-Ag) is one of the
potential biomarkers for this diagnosis. Nanomaterial-based detection systems were shown to be efficient with different clinical
biomarkers. In this study, we have demonstrated strontium oxide-modified interdigitated electrode (IDE) fabrication by the sol-gel
method and characterized by scanning electronmicroscopy and high-powermicroscopy. Analysis of the bare devices indicated the
reproducibility with the fabrication, and further pH scouting on the device revealed that the reliability of the working pH ranges
from 3 to 9. The sensing surface was tested to detect SCC-Ag against its specific antibody; the detection limit was found to be 10
pM, and the sensitivity was in the range between 1 and 10 pM as calculated by 3𝜎. The specificity experiment was carried out using
major proteins from human serum, such as albumin and globulin. SCC-Ag was shown to be selectively detected on the strontium
oxide-modified IDE surface.
1. Introduction
Cervical cancer is a gynecological issue originating from the
cervix due to tissue invasiveness in the uterine cervix by
uncontrolled cell division [1]. Cervical cancer is a burden to
women’s health and is the second leading cause of cancer-
related death globally, accounting for ∼250,000 cases every
year [1–3]. Cervical cancer is generally caused by infection of
the human papillomavirus (HPV), a common viral infection
reported widely [4]. Almost all cervical cancer cases are
attributable to the HPV infection, and untreated or unde-
tected cases will result in life-threatening illness. Identifying
cervical cancer at an earlier stage with suitable biomarkers
will aid in the treatment of this complication and avoid
disease spread to other organs [5].
Most cervical cancer cases are of squamous cell type
origin [6]. Squamous cell carcinoma antigen (SCC-Ag) is
a tumor antigen of the TA-4 subfraction and is a recog-
nized prognostic factor for squamous cell cervical carcinoma
(SCC) [7]. It was found that 95% of SCC occur in the
uterine cervix, neck, and lung [8–10], and 83% are detected
in the region of the uterine cervix. Thus, SCC-Ag is a
well-proven biomarker for cervical cancer and has been
identified to have a higher association between cervical
cancer and SCC [11–13]. Looi et al. [14] have analyzed
suitable biomarkers for cervical cancer by comparing the
glycoprotein CA125 and SCC-Ag. The levels of CA125 and
SCC-Ag were determined in the patients using the enzyme-
linked immunosorbent assay; they found elevation of SCC-
Ag in the serum. Their research concluded that SCC-Ag is a
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better tumor biomarker than CA125 to detect cervical cancer
efficiently.
Because SCC-Ag is a suitable biomarker for cervical
cancer, identifying and quantifying the critical level of SCC-
Ag aremandatory to detect and treat cervical cancer. Creating
a high-performance biosensor with a lower limit of SCC-Ag
detection will aid the treatment of cervical cancer patients.
The detection limit of any given biosensor is mainly depen-
dent on two factors, the binding affinity between the probe
and analyte and making proper surface functionalization
without noticeable biofouling [15, 16]. In the past, probes
including DNA, RNA, antibody, peptide, and aptamer have
been considered to detect diseases with improved detection
limits [17–20]. Surface functionalization for biomolecular
attachment is highly associated with good biosensors, espe-
cially if it has been proven that high and proper arrangements
of the analytes or molecules to be detected on the sensing
surfaces enhance the limits of detection. Different chemical
and physical methods were demonstrated either with a linker
or directly immobilized to the biomolecules on the sensing
surfaces. Among them, nanoparticles have attracted greater
attention in the field of biosensors to improve detection due
to nanoparticle-mediated enhancement of the surface area
[15, 21–23].
Various nanomaterials have been used in the field of
biosensors, especially in the medical field, for imaging, tar-
geting, identification and targeted therapy. Among different
nanomaterials, nanoparticles have attracted more attention
for creating high-performance biosensors. Nanoparticles,
including gold, silver, iron, copper, and graphene, have been
used with appropriate surface functionalization to conjugate
the desired probe [24, 25]. Additionally, strontium is a
developing material that has been applied in different fields
of interest, including as a biosensor [26–28]. Strontium is
a widely used attractive perovskite type of material due to
its different chemical and physical properties, as well as
its applications in an electronic field as a capacitor and
catalysis [29]. In this work, we used strontium oxide for
surface functionalization to specifically detect SCC-Ag, and
the desired strontium oxide surface is made on interdigitated
electrode (IDE) that was immobilized with an SCC-Ag anti-
antibody. The primary role of this research was to generate
a sensor that can demonstrate high-performance detection
with significant nonfouling and that can mimic for other
clinically important targets. The significance of this research
is to enhance the detection level of SCC-Ag to generate an
early detection strategy that is expected to play a pivotal role
in decreasing mortality due to SCC.
2. Materials and Methods
2.1. Reagents and Biomolecules. SCC-antigen was procured
fromRANDOXLife Sciences (Malaysia). Anti-SCC antibody
was purchased fromNext Gene (Malaysia). Strontium oxide,
(3-aminopropyl)triethoxysilane (APTES), globulin, serum
albumin, and Tween 20 were purchased from Sigma Aldrich
(USA). All obtained reagents and chemicals were stored
according to the manufacturers’ recommendations. All pH
solutions were from Hanna Instruments (Malaysia).
2.2. Fabrication of the IDE Sensor Surface. The IDE fabri-
cation process was followed as described previously with
different physical modifications on the top layer [18]. Briefly,
after oxidation of the silicon wafers at high temperature, the
etching process was performed using aluminum. Following
etching, other developing processes were carried out similar
to those in our earlier procedure. Finally, the strontium
oxide layer was overlaid on the top for ultimate biomolecular
immobilization. Before proceeding with strontium oxide
attachment, both the sensing surface and strontium oxide
were initially washed with 1 M potassium hydroxide (pH
9.0). To immobilize the strontium oxide on the IDE sensor
surface, it was first mixed with 2% APTES (diluted in 70%
ethanol) and kept at room temperature (RT) for 3 hrs. After
the binding of strontium oxide and APTES, the unbound
molecules were separated by centrifugation at 10,000 × g for
10 min. The APTES bound strontium oxide sediment was
washed 3 times with 70% ethanol, followed by washing with
water and immobilization of the antibody on the IDE sensor
surface.
2.3. Antibody Immobilization on the IDE Sensor Surface via
Strontium Oxide. The antibody was immobilized on the IDE
sensor surface using the following steps. After performing the
above steps with strontium oxide attachment, 2% glutaralde-
hyde (GLU) diluted in PBS was added onto the APTES-
strontium oxide-modified surface and incubated for 1 h at RT.
Next, the surface was washed 3 times with PBS to remove
unbound GLU. On the GLU-modified surface, 200 nM of
SCC-Ag antibody diluted in PBS was added, followed by
incubation for 1 h at RT and washing 3 times with PBS to
remove the unbound antibody. Finally, 1M ethanolamine was
added onto the remaining IDE surface to reduce biofouling.
2.4. Detection of SCC-Ag on the Strontium Oxide-Antibody-
Modified IDE Surface. SCC-Ag was detected on the stron-
tium oxide antibody-modified IDE sensor surface. First, the
antibody was immobilized on the sensor surface using the
above method. The baseline current was noted at this point.
Thereafter, 5 𝜇l of 100 nM SCC-Ag was dropped onto the
surface, followed by incubation for 30min at RT and washing
3 times with PBS to remove unbound SCC-Ag. The changes
in the current levels indicate the interaction of the antibody
and SCC-Ag.
2.5. Limit of Detection: SCC-Ag on the Strontium Oxide
Antibody-Modified IDE Surface. To check the limit of detec-
tion with SCC-Ag, different concentrations of SCC-Ag (100
fM to 100 nM) were added independently onto the strontium
oxide antibody-modified IDE sensor surface. The current
changes were noted before and after SCC-Ag immobilization.
Between each immobilization, the surface was washed five
times with PBS buffer to remove unbound SCC-Ag.
2.6. Specific Detection of SCC-Antigen on the Strontium-
Antibody-Modified IDE Surface. To check the specific detec-
tion of SCC-Ag, after immobilizing the SCC-Ag antibody, the
proteins (globulin; albumin) abundant in the blood serum
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Figure 1: Surface of the interdigitated electrode. (a) Representation for the bare andmodified sensing surface. (b)Three-dimensional images
of the bare and modified sensing surface.
and SCC-Ag were added independently, and the current
changes were noted after the incubation, followed by washing
as described above. Additionally, a control experiment was
carried out with a different antibody (anti-factor IX) at 200
nM that was immobilized on the IDE substrate, followed by
blocking with ethanolamine and the addition of 50 nM of
SCC-antigen to check the specific detection of SCC-antigen.
3. Results and Discussion
Identifying and analyzing the condition and severity of
diseases are mandatory in the field of medicine [30–32]. The
biosensor is the established technology that helps to detect
the basic to life-threatening diseases [33, 34]. Improving the
biosensor obviously enhances the limit of detection with
high-performance analysis. Immobilizingmore biomolecules
with the proper orientation on the sensing surface is one
of the success keys to improving the limit of detection [35–
38]. In this work, we used strontium oxide to immobilize the
antibody on the IDE sensor surface to detect cervical cancer.
This set up improved the antibody immobilization and limit
of detection of SCC-Ag. The schematic representation of
the attachment of strontium oxide and antibody for the
interaction of SCC-Ag is displayed in Figure 1(a). Figure 1(b)
shows three-dimensional microscopic images of the bare
surface between the fingered electrodes and strontium oxide-
immobilized surface on the IDE sensor surface. The IDE
surfaces were fabricated within the micron scale range with
smooth and soft edges. The size of the gap between the
fingers is∼5 𝜇m. Figure 1(b) clearly shows the immobilization
of strontium oxide on the IDE sensor surface, and there
is an apparent difference from the bare device. On the
strontium oxide-modified surface, the anti-SCC-Ag antibody
was immobilized to detect SCC-Ag. The higher amount of
antibodies was occupied on the IDE surface with the link of
strontium oxide nanoparticles due to the enhanced surface
area (Figure 1(b)), and it lowered the limit of detection of
SCC-Ag. Before immobilizing the strontium on the IDE
sensor surface, to check the reproducibility, three different
batch preparations of IDE surfaces were checked with the
IDE sensor. Figure 2(a) shows the three different bare IDE
sensor surfaces; all three batches showed a similar response
of current changes without significant differences. Thus, the
reproducibility of the IDE sensor surface was good. The
surface morphology of the bare device was observed under
scanning electron microscopy and is displayed in Figure 2(a)
(inset).
3.1. pH Scouting on the IDE Surface. Because the solution
conductivity is highly dependent on the dissociation of a
dissolved substance in the solution in the form of ions, before
detecting SCC-Ag, we checked the surface with different
pH solutions to assess the capability of carrying the electric
current. When the solution was added onto the electrode,
the positive ions moved to the cathode and the negative ions
moved toward the anode. We tried solutions with pH values
from 1 to 12 on the IDE surface. In general, the acidic pH
enhances the H+ ions and the alkaline pH yields more OH-
ions in the solution. As shown in Figure 2(b), from pH 10,
the current change was higher and the pH values from 3 to 9
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Figure 2: Surface characterization of IDE. (a) Reproducibility test on the bare devices by IDE. Three devices were tested. SEM image of the
surface is displayed as the figure inset. (b) pH scouting. Different pH solutions from 1 to 12 were used.
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Figure 3: Molecular attachments on IDE. Different molecules were
attached as per the scheme. It includes bare, strontium oxide,
antibody, ethanolamine, and antigen.
show the lower current change. Apparently, pH values above
10 are considered to have fouling effect for biomolecular
interaction. On the other hand, a pH until 9 falls under the
condition with an insignificant noise or background level.
From this result, we concluded that a pH range from 3 to 9
is suitable for our experiments, and we used the near neutral
pH 7.4 for further experiments.
3.2. Detection of SCC-Ag on the Strontium Oxide Antibody-
Modified Surface. After pH optimization, SCC-Ag was
detected on the strontium oxide antibody-modified surface.
To that end, 100 nM SCC-Ag was dropped onto the antibody
immobilized surface. Figure 3 shows the immobilization steps
of each biomolecule on the IDE surface. The bare IDE (black
line) shows the current approximately 4 ×10−5 in a linear
fashion. After adding the APTES-modified strontium, the
current was reduced to 3 ×10−6 (orange line). From these
changes, we confirmed the immobilization of strontiumoxide
on the IDE surfaces and the declining change was due to
the charged strontium oxide particle with APTES.Thereafter,
when we added the antibody, it increased the current to 2
×10−5, obviously in the reverse direction due to the opposite
charge of the antibody compared with that of the strontium
oxide with APTES. Next, we blocked the sensing surface with
ethanolamine; the current was further increased to 3 ×10−5 in
the same direction.These changeswith the current confirmed
the proper binding of the immobilized biomolecules on the
sensing surface. Finally, when we added SCC-Ag, the current
was decreased from 3 ×10−5 to the lowest current level. This
is the indication of the binding of SCC-Ag with its antibody.
3.3. Limit of Detection of SCC-Ag. After detecting 100 nM
of SCC-Ag on the strontium antibody-modified surface, to
evaluate the limit of detection, we titrated SCC-Ag from the
lower femtomolar (100 fM) until the nanomolar range (100
nM). After adding ethanolamine, 100 fM SCC-Ag was added,
and the current change was noticed. Thereafter, upon adding
each concentration from the above lowest to the highest (100
nM) concentration, the changes in the current were noted for
each concentration. As shown in Figure 4(a), ethanolamine
showed a current range >3 ×10−5. Upon adding different
concentrations of SCC-Ag, notable changes were observed
in the current. However, with SCC-Ag concentrations of 100
fM and 1 pM, no significant changes were found in the
current and the responses were close to that of ethanolamine.
Thereafter, when we added 10 pM SCC-Ag, the current
level was decreased from 1.5 ×10−5. Additionally, when we
increased the concentration, the changes in the current were
also gradually decreased. From this result, we confirmed that
the limit of detection of SCC-Ag on the strontium oxide
antibody surface was 10 pM. The concentrations of 100 fM
and 1 pM SCC-Ag did not display significant changes in the
current. However, with 10 nM SCC-Ag, the current changed
to 1.5×10−5, which could estimate the limit of detection. From
the obtained data, the sensitivity of the device to detect SCC-
Ag was calculated based on 3𝜎 using ethanolamine followed
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Figure 4: SSC-Ag analysis on the IDE. (a) Concentration-dependent analysis. The IDE surface was tested from 100 fM to 100 nM SSC-Ag.
(b) Sensitivity analysis. The 3𝜎 calculation was followed as indicated.
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Figure 5: Specificity analysis on IDE. (a) Different serumproteins were tested at the 50-nM level. SSC-Ag, albumin, and globulin were tested.
(b) Interaction of SCC-Ag against anti-factor IX antibody. The specificity of the anti-SCC antibody used in this study is clearly shown.
by the buffer curve as the reference, and it was in the range
between 1 and 10 pM.
3.4. Specific Detection of SCC-Ag. After checking the limit
of detection, to evaluate the specific detection of SCC-Ag,
upon immobilizing the ethanolamine, we dropped different
unrelated proteins, including albumin and globulin, whose
levels are abundant in human serum. Albumin in a normal
human being is at the level of 45 mg mL−1, whereas that of
globulin has been found to be 46 mg mL−1 [15]. As shown
in Figure 5(a), after ethanolamine addition (the baseline),
albumin and globulin showed no change in the current.
Additionally, when we added SCC-Ag, a clear decrement
was noted in the current with 50 nM SCC-Ag. This result
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indicated that SCC-Ag is specifically bound with its antibody
and shows accurate detection of SCC-Ag. Moreover, to check
the specificity, different antibodies (besides SCC antibody)
were immobilized on the IDE substrate and were checked
for interaction with SCC-antigen. As shown in Figure 5(b),
SCC-antigen could not interact with factor IX antibody
(no changes in the current), and this result confirmed that
the SCC antibody and antigen interactions shown in study
are specific. This research potentially addresses the current
expectations in the field of medicine. Current identification
methods are not sufficiently sensitive to quantify the lower
level of SCC-Agwith higher nonfouling.With suitable surface
functionalization using strontium oxide for probe immobi-
lization, the detection level was improved and no significant
biofouling was found [39, 40]. The primary advantage of
our study understood completely the mechanism of surface
chemical functionalization, especially using the strontium
oxide-modified surface that is suitable for downstream appli-
cations. The stakeholders and potential users of the research
proposed include researchers, the local population, andmed-
ical practitioners. Due to the early diagnosing strategy with
a higher specificity, the system demonstrated here will aid
in precautionary actions against further spreading squamous
cell carcinoma in the human physiological system.
4. Conclusion
Cervical cancer is a life-threatening disease, and it affects the
women’s health. Squamous cell carcinoma antigen (SCC-Ag)
is awell-knownbiomarker for cervical cancer. Early detection
of cervical cancer using a suitable probe has improved the
cure rate. In this work, we prepared a strontium oxide-
modified IDE sensor surface to detect SCC-Ag against its
antibody as the probe. The limit of detection was found at 10
pM, and the sensitivity range was from 1 to 10 pM. Moreover,
a specific detection experiment was carried out using the
serumproteins albumin and globulin, aswell as different anti-
bodies. SCC-Ag was demonstrated to be specifically detected
on the strontium oxide-modified IDE sensor surface. This
research demonstrates an efficient method to detect SCC-Ag
that can be used for other disease biomarker detection.
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